Tech Center 1600 • Art Units: 1633 1647 1653 1655
This examiner grants 55% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17996966 | NOVEL T-CELL SPECIFICITIES AND USES THEREOF | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18148886 | TARGETING BCL11A ENHANCER FUNCTIONAL REGIONS FOR FETAL HEMOGLOBIN REINDUCTION | Non-Final OA | Massachusetts Institute of Technology |
| 17618774 | RECOMBINANT AD35 VECTORS AND RELATED GENE THERAPY IMPROVEMENTS | Final Rejection | University of Washington |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy